ClinicalTrials.gg
RecruitingNCT05268588Kushal MaaUpdated Apr 1, 2026

mHealth India Postnatal Health Intervention Effectiveness

An interventional study of MESSSSAGE intervention in Health Knowledge, Attitudes, Practice, Post Partum Depression and Breastfeeding, sponsored by University of California, San Francisco. Recruiting at 3 sites in India. Open to female participants aged 18 Years to 49 Years. Per ClinicalTrials.gov, last updated 2026-04-01.

Primary conditionBreast FeedingRegistry: BehaviorReclassifiedWhy we changed it
Registry
Behavior — the first condition term the registry derived for this study.
ClinicalTrials.gg
Breast Feeding
Why
  1. The study's listed conditions name Breast Feeding, a narrower term within Behavior.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of California, San Francisco · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
2,100
Allocation
Randomized
Ages
18 Years to 49 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 13 studies in Breast Feeding by University of California, San Francisco — 3 open to participants now, 3 under way, none of them phase 3. Breast Feeding · University of California, San Francisco.

Planned enrollment
2nd of 11
2,100 · median 205
Started
2025
the only one that year
No phase
11 of 13
2 open now
Registered
11th of 13
by date

Among the 13 studies in Breast Feeding by University of California, San Francisco, this one is the 2nd largest by planned enrollment of the 11 interventional ones that give a count, is the only one that started in 2025, is one of 11 with no phase, and was the 11th registered.

Breast Feeding

1,083 studies on the registry are indexed under Breast Feeding; 216 are open to participants now.

Browse Breast Feeding studies →

Open to participants now

3 of the 13 studies in Breast Feeding by University of California, San Francisco are open now, in 3 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Who these studies take

Of the 125 Breast Feeding studies recruiting now, 65 (52%) set no upper age limit and 58 (46%) stop at 75 or younger; 52 take children under 18; 75 take healthy volunteers.

This study: 18 Years to 49 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Breast Feeding by University of California, San Francisco, or all of them as a file.
02

Study summary

The goal of this study is to assess the effectiveness of a culturally-tailored mobile interactive education and support group intervention to supplement standard postpartum care activities in comparison to standard care alone on health-related behaviors and health outcomes in a randomized controlled trial among 2100 postpartum Indian women living in 3 geographically diverse Indian states to estimate the impact on maternal and neonatal health-related knowledge, health-related behaviors, and health outcomes. The investigators also seek to characterize mechanisms of impact including knowledge, social support, self-efficacy, and behavior change, and determine the cost-effectiveness.

Read the detailed description

Maternal and infant mortality remain high in Northern India, at 167 per 100,000 live births and 49 per 1,000 live births, respectively. Access to perinatal care is increasing, yet gaps in care access and quality persist, particularly in peri-urban and rural areas. Steep drops in the perinatal continuum of care occur postpartum, with only 64% of mothers and 24% of infants receiving postpartum care, despite continuing maternal and infant risk. Ensuring continuity of high quality perinatal care into the postpartum period is key for maternal and infant health outcomes.

Postpartum care and support have received less focus than other perinatal continuum of care indicators yet are important for optimizing maternal and neonatal health and wellbeing. Significant logistical, sociodemographic and sociocultural barriers impede postpartum care access in India including postpartum seclusion, women's limited mobility, and geography. To overcome these barriers and reduce women's postpartum isolation through social support, an international team of maternal and infant health researchers and clinicians developed and pilot-tested a culturally-tailored mobile interactive education and support group intervention to supplement standard postpartum care activities: Maa Shishu Swasthya Sahayak Samooh (maternal and child health support group: MeSSSSage). MeSSSSage uses a provider-moderated group approach to increase women's communication with providers, to refer them to in-person care, and to connect them with a virtual social support group. Participants are recruited in late pregnancy and have 26 education and support sessions via audioconference facilitated by community health workers (two prenatal and weekly postpartum sessions through six months), plus engage in a text chat group. Group-based mHealth models are low cost and likely to be cost-effective. The participants overcome logistical and sociocultural barriers to postnatal care, and the participants have high acceptability and efficiency when used for other health issues. The pilot study results indicated high acceptability and feasibility and suggest preliminary effectiveness on maternal knowledge of best practices for facilitating postpartum health. Understanding intervention effectiveness on maternal health behaviors, key intervention pathways, and cost-effectiveness will inform the scalability of this intervention, with the potential to inform other similar ones.

The goal of this study is to assess the effectiveness of the 8-month MeSSSSage intervention in comparison to standard care alone on health-related behaviors and health outcomes in a fully powered randomized study, to test the conceptual model through analyzing the intervention's mechanisms of impact, and to determine cost-effectiveness. The investigators propose a randomized controlled trial (RCT) among 2100 postpartum Indian women living in 3 geographically diverse Indian states to estimate the impact of MeSSSSage on maternal and neonatal health-related knowledge, health-related behaviors, and health outcomes. The specific aims are to:

Aim 1: Estimate the effectiveness of a mobile interactive education and support group intervention (MeSSSSage) on postpartum behaviors for optimizing maternal and neonatal health in India. Within the 8-month RCT, the investigators will test the impact of the MeSSSSage intervention compared to standard care within 2100 Indian women. The primary effectiveness outcomes are exclusive breastfeeding, met need for postpartum contraceptives, and postpartum mental health. Secondary outcomes will incorporate additional maternal health behaviors and maternal and neonatal outcomes (e.g., appropriate care-seeking for illness, etc. see Table 2).

Aim 2: Characterize the mechanisms of impact of a mobile interactive education and support group intervention (MeSSSSage) on maternal and neonatal health in India. Within this RCT, the investigators will delineate the specific pathways through which the MeSSSSage intervention operates, including knowledge, social support, self-efficacy, and behavior change. The investigators will conduct mediation analyses using modern structural equation modeling and causal inference methods to identify the main drivers of the intervention impact to inform scalability.

Aim 3: Determine the cost-effectiveness of a mobile interactive education and support group intervention (MeSSSSage) in improving postpartum maternal and neonatal health as compared to the standard of care. The investigators will conduct cost analyses to determine intervention and standard of care costs, paying special attention to the value of social network belonging, and calculating opportunity cost. The investigators will conduct cost-effectiveness analysis (CEA) overall and stratified by social connectedness level to estimate the incremental cost-effectiveness ratio (ICER) of MeSSSSage in increasing exclusive breastfeeding, met need for postpartum contraception, and reducing postpartum depression, as compared to standard of care.

Perinatal educational and social support interventions are important for both physical and emotional well-being. The investigators anticipate that supplementing women's perinatal care within the postnatal period through an intervention approach that overcomes prevalent logistical and sociocultural challenges to care access through mHealth will have tangible impacts on the health and well-being of new mothers and infants. Estimating the impact of a mobile group intervention on maternal and infant health will inform scale-up of this accessible, acceptable, and feasible intervention among perinatal South Asian women, and can broadly inform the optimization of perinatal group care models for ensuring continuity across the full continuum of care.

03

Conditions studied

  • Health Knowledge, Attitudes, Practice
  • Post Partum Depression
  • Breastfeeding
  • Nutrition, Healthy

Browse trials for

Keywords

  • mHealth
  • group care
04

In context

Breast Feeding Reclassified

1,083 studies on the registry are indexed under Breast Feeding; 216 are open to participants now.

This study's planned enrollment of 2,100 is above the median of 100 across 846 interventional studies indexed under Breast Feeding.

Browse Breast Feeding studies →

Lead sponsor

University of California, San Francisco is the lead sponsor of 2,172 studies on the registry; 370 are open to participants now.

Of its 269 completed or terminated interventional studies of FDA-regulated products, 203 (75%) have results posted.

Compared within Breast Feeding, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Behavior. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years to 49 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant (28-32 weeks gestational age)
  • Speak local language
  • Personal mobile phone or willing to accept study phone
  • Able to provide

Exclusion criteria

Exclusion Criteria:

  • Do not speak local language
  • No personal phone or unwilling to accept study phone
  • Unable to provide
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

06

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
2,100 participants (estimated)

Study arms

  • Experimental
    Intervention Arm

    The mHealth education and social support intervention includes tailored weekly educational content via interactive voice recognition and an android application, a phone-based provider-moderated group discussion, a provider-moderated group text chat, and referral to care as needed. Individuals are enrolled into groups of 20, have two intervention sessions prenatally and then have weekly meetings through six months postpartum for a total of 26 sessions.

    Behavioral: MESSSSAGE intervention

  • No intervention
    Control Arm

    Standard postnatal care.

Interventions

  • BehavioralMESSSSAGE intervention

    group mHealth education and social support intervention

07

What researchers measure

Primary outcomes

  1. Exclusive breastfeeding

    Proportion of participants reporting exclusive breastfeeding at 3 and 6 months

    Time frame: 6 months

  2. Postpartum depression

    Proportion of participants reporting postpartum depression symptoms at 3 and 6 months

    Time frame: 6 months

  3. Postpartum family planning adoption

    Proportion of participants not wanting to become pregnant immediately having started a modern contraceptive method within 6 months postpartum

    Time frame: 6 months

Secondary outcomes

  1. Maternal and neonatal danger sign knowledge

    Proportion of participants correctly identifying all maternal and neonatal danger signs by 6 months

    Time frame: 6 months

  2. Maternal and neonatal health care use

    Proportion of participants seeking healthcare for maternal and neonatal concerns within 6 months

    Time frame: 6 months

  3. Neonatal preventive health care use

    Proportion of participants having achieved target neonatal preventive care visits within 6 months

    Time frame: 6 months

  4. Infant vaccination

    Proportion of participants having achieved recommended childhood vaccination schedule by 6 months

    Time frame: 6 months

08

Study locations

2 of 3 sites recruiting
  • Post-Graduate Institute for Medical Education and Research
    Chandīgarh, Haryana, India
    Recruiting
  • Sangath
    Bhopal, Madhya Pradesh, India
    Recruiting
  • Indraprastha Institute for Information Technology
    New Delhi, National Capital Territory of Delhi, India
    Not yet recruiting
09

References and documents

Publications

  • El Ayadi AM, Duggal M, Gopalakrishnan L, Bagga R, Singh P, Lin T, Bhan A, Saunik S, Verma GS, Ahuja A, Kaur J, Tugnawat D, Gujarathi S, Singh A, Khan A, Chandke D, Dhir SK, Dhakne-Palwe S, Kumar P, Patil M, Kumar S, Vasaikar N, Weil L, Diamond-Smith N. Effectiveness of Kushal Maa, a group-based mhealth interactive education and social support intervention for maternal and neonatal health outcomes: study protocol for a multisite randomised controlled trial in India. BMJ Open. 2025 Jun 27;15(6):e104213. doi: 10.1136/bmjopen-2025-104213. PubMed 40578858 ↗

Individual participant data

Plan to share: Yes — After study completion, de-identified data will be made available to other researchers upon reasonable request and completion of a data sharing agreement.

Supporting information: Study protocol, Statistical analysis plan

Time frame: On study completion

Access criteria: Request of study team.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for May 2027, 28 months after the start.

Of 505 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 28 months is above that.

Counting every sponsor, half of 513 studies reached it within 12 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 24, 2022
First posted
Mar 7, 2022
StartActual
Jan 20, 2025
Primary completionEst.
May 31, 2027
CompletionEst.
May 31, 2027
Last update
Apr 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05268588
Responsible party
Sponsor
First posted
Mar 7, 2022
Start date
Jan 20, 2025
Primary completion
May 31, 2027 (estimated)
Completion
May 31, 2027 (estimated)
Last update
Apr 1, 2026

Study contacts

Alison M El Ayadi, ScD
Contact
alison.elayadi@ucsf.edu
415-476-5877
Nadia G Diamond-Smith, PhD
Contact
nadia.diamond-smith@ucsf.edu
415-476-5616
Alison M El Ayadi, ScD
principal investigator · University of California, San Francisco
Nadia G Diamond-Smith, PhD
principal investigator · University of California, San Francisco

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion